Trial Profile
A four-way crossover phase I trial investigating ICE 1201 (Metaxalone submicron) for the treatment of acute, painful musculoskeletal conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2016
Price :
$35
*
At a glance
- Drugs Metaxalone (Primary)
- Indications Musculoskeletal disorders
- Focus Pharmacokinetics
- 15 Apr 2016 New trial record